Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Ketamine for Postoperative Avoidance of Depressive Symptoms: The K-PASS Feasibility Trial


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05233566

Organisation Name: Washington University School of Medicine

Overal Status: Recruiting

Start Date: April 25, 2022

Last Update: September 23, 2022

Lead Sponsor: Washington University School of Medicine

Brief Summary: This protocol describes a feasibility trial that will evaluate the feasibility of conducting a full-scale phase 3 trial testing the hypothesis that a postoperative sustained, low-dose ketamine infusion can prevent postoperative depressive symptoms when administered to a targeted population of neurosurgical patients with a history of depression.

Conditions:
  • Postoperative Depression


Total execution time in seconds: 0.65212297439575